LactiGo

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: LactiGo
Generic name: MENTHOL
Manufacturer: LactiGo, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 849c3601-2bc8-0991-e053-2a91aa0a5e7f
SPL ID: 213e8489-762b-461f-e063-6394a90a64a3
Version: 4
Effective date: 2024-09-03
Source export date: 2026-10-27
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/be847f9aea8d80a2cb7e9771acd1143be084664192ecf8f5be8ac1024116f4f0/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:12:52

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		LactiGo	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		LactiGo, Inc.	openfda.manufacturer_name
ndc	package	72481-101-32	openfda.package_ndc
ndc	package	72481-101-03	openfda.package_ndc
ndc	product	72481-101	openfda.product_ndc
ndc11	package	72481010132	derived:openfda.package_ndc
ndc11	package	72481010103	derived:openfda.package_ndc
rxcui		866128	openfda.rxcui
spl id		213e8489-762b-461f-e063-6394a90a64a3	id
spl set id		849c3601-2bc8-0991-e053-2a91aa0a5e7f	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes and mucous membranes. If contention worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. Do not apply to wounds or damaged skin. Do not bandage tightly.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.